Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Keryx Biopharmaceuticals provides update from safety extension study of Zerenex

Nov. 12, 2013

New Hsp70 inducers presented by scientists in the Netherlands

Nov. 11, 2013

Phase II trial of Zerenex in NDD-CKD meets all primary and key secondary endpoints

Nov. 7, 2013

Genkyotex begins multinational phase II study of NOX inhibitor

Nov. 5, 2013

Development of Kremezin discontinued in the U.S. and Europe

Oct. 31, 2013

Sophiris begins dosing in PLUS-1 phase III trial of PRX-302

Oct. 30, 2013

Enrollment complete in phase III trial of ZS-9 for treatment of hyperkalemia

Oct. 24, 2013

Evotec and AstraZeneca collaborate on treatments for chronic kidney disease

Oct. 22, 2013

Relypsa reports topline data from phase IIb trial of patiromer

Oct. 18, 2013

Phase I trial of KEA-0447/KRP-EPA605 for treatment of overactive bladder begins

Oct. 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...